IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

BASF Sells U.S. Pharma Unit to Dr. Reddy's

2:33 AM MDT | April 30, 2008 |

Natasha Alperowicz

BASF says it has signed a definitive agreement to sell its manufacturing facility at Shreveport, LA and the related contract manufacturing business for finished pharmaceuticals to Dr. Reddy's Laboratories (Hyderabad) for an undisclosed price. The 42-acre Shreveport facility manufacutures and packages prescription and over-the-counter pharmaceutical products, liquids, tablets and creams for the North American market. BASF says it is selling the business to concentrate on core operations in the care chemicals division, which include custom synthesis services...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa